2BB score and signals
Neuropace, Inc.’s current 2BB score is 54 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 68 | High |
| Momentum | 60 | Improving |
| Financial strength | 27 | Weak |
| Quality | 97 | Very Strong |
| Risk | 48 | Moderate |
Neuropace, Inc. (NPCE) Stock Score & Signals
Neuropace, Inc. (NPCE) trades on NASDAQ. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 54 out of 100.
Company facts
| Founded | 1997 |
| Employees | 220 |
| 52-week range | $9.22 – $19.60 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-01 | — | -0.0778 | — | $28.96M |
| 2026-11-02 | — | -0.0918 | — | $27.71M |
| 2026-08-10 | — | -0.2155 | — | $23.11M |
| 2026-05-12 | -0.2 | -0.2346 | $22.07M | $22.08M |